BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Feb. 7, 2007
View Archived Issues
Push By AstraZeneca Includes COPD Deal Worth Up To $500M
LONDON - AstraZeneca plc went through a hyperactive round last week of licensing and acquisitions, sealing deals worth $650 million. (BioWorld International)
Read More
Circassia Raises £6M To Move Its Allergenic Products Ahead
Read More
Study Confirms Prion Protein As Therapeutic Target In CJD
Read More
ScanBalt Promoting Baltic Biotechnology Cooperation
Read More
AstraZeneca Buys Antiviral Firm Arrow For $150M Cash
Read More
Jerini Extends Pact With Baxter For New Hemophilia Drugs
Read More
NicOx Details Offer To Raise €130M
No Abstract
Read More
Europe Moves Ahead On Advanced Therapy Rules
Read More
Other News To Note
Read More